✦ LIBER ✦

Miliary brain metastases in 2 cases with advanced non-small cell lung cancer harboring EGFR mutation during gefitinib treatment

✍ Scribed by Mochizuki, Sayaka; Nishimura, Naoki; Inoue, Akira; Murakami, Koji; Nukiwa, Toshihiro; Chohnabayashi, Naohiko

Book ID: 119357614
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 892 KB
Volume: 50
Category: Article
ISSN: 2212-5345
DOI: 10.1016/j.resinv.2012.06.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Gefitinib in Patients With Ad

First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

✍ Sequist, L. V.; Martins, R. G.; Spigel, D.; Grunberg, S. M.; Spira, A.; Janne, P 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 228 KB

Gefitinib in Patients with Brain Metasta

Gefitinib in Patients with Brain Metastases from Non–Small-Cell Lung Cancer: Review of 15 Clinical Cases

✍ Yoshinobu Namba; Takashi Kijima; Soichiro Yokota; Manabu Niinaka; Satoko Kawamur 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 512 KB

EGFR / HER2 / HER3 expression in tumour

EGFR / HER2 / HER3 expression in tumour and gefitinib treatment in Chinese patients with advanced non-small cell lung cancer

✍ Jianming Xu; Emei Gao; Yu Han; Yang Zhang; Suxia Li; Xiaoqing Liu; Zhiqiang Li; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 282 KB

The EGFR mutation and its correlation wi

The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer

✍ Zhang, X.-T. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 301 KB

EGFR mutations and HER2/3 protein expres

EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib

✍ Jian Ming Xu; Yu Han; Hai Qing Duan; E. Mei Gao; Yang Zhang; Xiao Qing Liu; Jing 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 521 KB

PCN37 A Pharmacoeconomic Analysis of the

PCN37 A Pharmacoeconomic Analysis of the Implementation of Gefitinib in the Treatment of Metastasized Non-Small Cell Lung Cancer (NSCLC) With Proven EGFR-TK Mutations

✍ J. Culig; M. Leppée; N. Skaron-Jakobovic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB